CNB Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$287K Sell
2,011
-209
-9% -$31.7K 0.11% 131
2026
Q2
$348K Sell
2,220
-355
-14% -$53.2K 0.14% 119
2026
Q1
$393K Hold
2,575
– – 0.17% 108
2025
Q4
$355K Sell
2,575
-499
-16% -$65.3K 0.15% 111
2025
Q3
$394K Sell
3,074
-261
-8% -$31.8K 0.16% 111
2025
Q2
$404K Sell
3,335
-1,026
-24% -$116K 0.19% 104
2025
Q1
$486K Sell
4,361
-1,761
-29% -$187K 0.25% 93
2024
Q4
$596K Sell
6,122
-973
-14% -$104K 0.28% 86
2024
Q3
$816K Sell
7,095
-1,684
-19% -$191K 0.38% 75
2024
Q2
$935K Sell
8,779
-6,281
-42% -$630K 0.45% 64
2024
Q1
$1.46M Buy
15,060
+198
+1% +$20.3K 0.71% 38
2023
Q4
$1.5M Sell
14,862
-647
-4% -$62.5K 0.81% 33
2023
Q3
$1.58M Sell
15,509
-511
-3% -$51.9K 0.93% 27
2023
Q2
$1.62M Sell
16,020
-688
-4% -$68.8K 0.95% 27
2023
Q1
$1.54M Buy
16,708
+495
+3% +$43.2K 0.94% 31
2022
Q4
$1.47M Sell
16,213
-43
-0.3% -$3.62K 0.92% 32
2022
Q3
$1.24M Buy
16,256
+271
+2% +$22.5K 0.84% 32
2022
Q2
$1.35M Sell
15,985
-1,267
-7% -$111K 0.87% 30
2022
Q1
$1.51M Buy
17,252
+679
+4% +$58.8K 0.85% 32
2021
Q4
$1.45M Sell
16,573
-77
-0.5% -$6.39K 0.79% 33
2021
Q3
$1.36M Buy
16,650
+1,907
+13% +$172K 0.82% 32
2021
Q2
$1.34M Sell
14,743
-27
-0.2% -$2.4K 0.84% 33
2021
Q1
$1.26M Buy
14,770
+370
+3% +$33.2K 0.87% 32
2020
Q4
$1.36M Buy
14,400
+1,174
+9% +$103K 1.03% 23
2020
Q3
$1.15M Sell
13,226
-1,292
-9% -$112K 0.97% 26
2020
Q2
$1.27M Buy
14,518
+744
+5% +$64.2K 1.12% 19
2020
Q1
$1.14M Buy
13,774
+2,424
+21% +$216K 1.22% 17
2019
Q4
$1.08M Buy
11,350
+1,327
+13% +$119K 0.91% 28
2019
Q3
$871K Buy
10,023
+1,951
+24% +$175K 0.81% 33
2019
Q2
$737K Buy
8,072
+1,131
+16% +$95.7K 0.63% 46
2019
Q1
$667K Buy
6,941
+412
+6% +$36.9K 0.34% 55
2018
Q4
$560K Buy
6,529
+974
+18% +$84.6K 0.36% 47
2018
Q3
$479K Buy
5,555
+42
+0.8% +$3.46K 0.27% 66
2018
Q2
$416K Buy
5,513
+98
+2% +$7.55K 0.24% 72
2018
Q1
$438K Buy
5,415
+268
+5% +$22.8K 0.26% 66
2017
Q4
$432K Hold
5,147
– – 0.26% 63

Other funds holding NVS

CNB Bank's NVS Position: Q3 2026 in Review

CNB Bank reduced its Novartis (NVS) stake by 9.4% in Q3 2026, selling an estimated $31.7K and leaving 2,011 shares worth $287K. The position accounts for 0.11% of the portfolio, ranked #131.

CNB Bank first reported a position in NVS in Q4 2017 and has held it in 36 quarters since. The position peaked at $1.62M in Q2 2023. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • CNB Bank held 2,011 shares of Novartis worth $287K as of Q3 2026.
  • CNB Bank sold 209 Novartis shares in Q3 2026, an estimated $31.7K.
  • Novartis made up 0.11% of CNB Bank's portfolio in Q3 2026, its #131 holding.
  • CNB Bank first reported a position in Novartis in Q4 2017 and has held it in 36 quarters since.
  • CNB Bank's Novartis position peaked at $1.62M in Q2 2023.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on CNB Bank's 13F filing for Q3 2026, filed 9 Nov 2026.